Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies

Clinical trial NCT04465487 · TERMINATED

Trial details

NCT number: NCT04465487
Sponsor: Regeneron Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck

Start date: 2020-10-05
Primary completion: 2025-02-07
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.